Stay updated on Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading with state subsections (Alabama, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Michigan, North Carolina, Oregon, Pennsylvania, Texas, Utah, Virginia, Wisconsin). Revision updated to v3.3.3.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check48 days agoChange Detected- Removed the government funding status notice banner from the page.SummaryDifference0.3%

- Check63 days agoChange DetectedNo notable additions or deletions were observed between the two screenshots of the Study Details page for NCT03817190.SummaryDifference0.3%

- Check91 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference2%

- Check98 days agoChange DetectedMinor page update: added revision tag v3.1.0 and removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) without adding new substantive content.SummaryDifference0.3%

Stay in the know with updates to Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.